Los Angeles-based ⁤Cedars-Sinai has appointed Ravi Thadhani, ⁢MD, ⁢as Executive⁣ Vice President of Clinical Affairs and Chief Medical Officer, effective October 15th. This ⁢leadership ​change marks a significant step for the health system as ‌it continues to prioritize patient care and medical⁤ innovation.

A⁤ Renowned⁣ Expert in Nephrology and Preeclampsia

Dr. thadhani brings extensive expertise to ‌Cedars-Sinai, recognized internationally as ‍a leader⁤ in the fields of nephrology (kidney disease) and ‍preeclampsia, ⁢a pregnancy complication. In his new role, he will be responsible for overseeing⁣ all aspects of clinical quality and safety, medical affairs, and ‌the establishment of‌ medical practice‌ standards⁣ across the Cedars-Sinai system and its affiliated hospitals.

Returning to Cedars-Sinai After National ‌Leadership Roles

Dr. Thadhani is not new ‌to Cedars-Sinai, having previously served as Vice Dean for Research and Graduate Research Education‍ and Chair of the Biomedical Sciences Department from 2017 to 2019. Following his tenure ‍at Cedars-Sinai, he⁤ held leadership positions at Mass ‍General Brigham in Somerville, Massachusetts, and most recently served⁢ as Executive Vice President for Health Affairs at⁣ Emory University​ in Atlanta, Georgia, and Executive Director of Emory’s Woodruff Health Sciences Center.

Succession and Continued Commitment to Excellence

Dr. Thadhani succeeds Richard Riggs, MD,‌ who is departing at the end​ of the year to pursue other ⁤opportunities. This transition ensures ⁤continuity of leadership and a continued focus on delivering exceptional healthcare​ services to the community. The appointment underscores Cedars-sinai’s commitment to ‍attracting and retaining top medical talent to advance ​its mission of⁢ improving the health and well-being of its patients.